Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated the PubMed publications description and added a revision label; core study data, endpoints, and eligibility criteria remain unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer displays the general funding/operating status notice. The core study information and links remain unchanged.SummaryDifference0.4%

- Check49 days agoChange DetectedThe new screenshot shows minor UI/layout adjustments on the study page with no changes to core study content such as title, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0 tag.SummaryDifference3%

- Check78 days agoChange Detected- Updated the revision/version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; removal of a Back to Top link. No substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.